ConMed (NSDQ:CNMD) today posted third quarter earnings that met EPS expectations on Wall Street and topped sales consensus. The Utica, N.Y.-based company posted profits of $5.8 million, or 20¢ per share, on sales of $202.3 million for the three months ended September 30, seeing profits shrink 19.1% while sales grew 6.4% compared with the same period […]
ConMed posts Street-beating Q2
ConMed (NSDQ:CNMD) today posted second quarter earnings that beat Wall Street expectations and lifted its sales growth guidance for the remaining year. The Utica, N.Y.-based company posted profits of $212.8 million, or 30¢ per share, on sales of $8.7 million for the three months ended June 30, for bottom-line growth of 42% on sales growth of 7.9% […]
Patent board invalidates SurgiQuest patent in Lexion spat
ConMed (NSDQ:CNMD) subsidiary SurgiQuest lost an intellectual property spat with Lexion Medical last week when a U.S. patent board invalidated a trocar patent. SurgiQuest sued Lexion last year, alleging infringement of patent no. 9,095,372B2, covering a “system and method for improved gas recirculation in surgical trocars with pneumatic sealing,” by Lexion’s line of Insuflow Synergy […]
ConMed shares rise on beat-and-raise Q1
Shares in ConMed (NSDQ:CNMD) have risen today after the medical device maker beat expectations on Wall Street with its first quarter earnings results. The Utica, N.Y.-based company posted profits of $10.7 million, or 37¢ per share, on sales of $202.1 million for the three months ended March 31, seeing a swing from red ink on the […]
Conmed’s Q4, 2017 profits surge on tax gain
Fourth-quarter and full-year profits surged for ConMed (NSDQ:CNMD) thanks to the tax reforms passed last year, as the medical device maker posted Street-beating sales and earnings numbers. Utica, N.Y.-based Conmed yesterday reported profits of $46.7 million, or $1.65 per share, on sales of $222.6 million for the three months ended Dec. 31, 2017. That’s a […]
Cerner taps former head of Philips North America to take over corner officer | Personnel Moves January 11, 2018
Cerner Corp. (NSDQ:CERN) said yesterday that it named Brent Shafer to serve as chairman & CEO effective Feb. 1. Shafer previously served as CEO of Philips‘ (NYSE:PHG) North America business. Cerner’s co-founder Cliff Illig has been serving as interim CEO and chairman of the board since July last year. Illig said he plans to resume […]
Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017
Hologic (NSDQ:HOLX) said this week its current prez and CEO Stephen MacMillan will stay on with the company, resolving rumors that he may depart it to take up the corner office at Zimmer Biomet (NYSE:ZBH). In an SEC filing, the Marlborough, Mass.-based company’s board said it approved a special “performance-based retention equity grant” to MacMillan after he had begun […]
ConMed ticks up on Street-beating Q3 results
ConMed (NSDQ:CNMD) shares ticked up today after the medical device company yesterday reported third-quarter results that topped Wall Street’s forecast and announced the retirement of its financial chief. Utica, N.Y.-based ConMed posted profits of $7.2 million, or 26¢ per share, on sales of $190.1 million for the three months ended Sept. 30, for a -1.9% […]
ConMed shares steady on Q2 beat
Shares in ConMed (NSDQ:CNMD) have stayed steady today after the device maker met expectation on Wall Street with its 2nd quarter earnings results. The Utica, N.Y.-based company posted profits of $6.1 million, or 22¢ per share, on sales of $197.2 million for the 3 months ended June 30, for bottom-line growth of 112.9% while sales grew […]
MedShape deals ExoShape ACL portfolio to ConMed
MedShape said today it inked a deal to divest its ExoShape ACL fixation system properties to ConMed (NSDQ:CNMD) for an undisclosed amount. The deal, which closed on Monday, includes Atlanta-based MedShape’s ExoShape femoral and tibial soft tissue fasteners designed to fixate soft tissue grafts in anterior cruciate ligament reconstructive surgery. “The ExoShape system has represented a […]
Lombard Medical CEO Hubbert, CFO Kullback step down | Personnel Moves, April 28, 2017
Lombard Medical Technologies (NSDQ:EVAR) said this month that its CEO Simon Hubbert and CFO William Kullback are stepping down from their positions, with Kurt Lemvigh stepping into the CEO role. Hubbert served as CEO for 6 years after joining the company in 2010, and will be replaced by Lemvigh, who has held positions with multiple companies, including […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 7
- Next Page »
